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As I look back on my year as president, I feel privileged to have
been elected to lead this vibrant organization.
It has been another exciting year for stem cell research and
a very successful year for our society. In December, we pub-
lished the ISSCR Guidelines for the Clinical Translation of Stem
Cells and an associated Patient Handbook on Stem Cell Thera-
pies. Both the guidelines and the handbook have received
a warm welcome from all quarters and have already been trans-
lated into several languages. The society has continued to attract
affiliates from national stem cell organizations and interfacing
communities, and plans are well advanced for two ISSCR-affili-
atedmeetings. Over the next year, we hope to work more closely
with the International Stem Cell Forum (ISCF), which is made up
of funders of stem cell research from around the world. We
benefited enormously from hiring the public relations company
Fleishman-Hillard, as this allowed us to engage more effectively
with themedia, an essential skill in this time of tremendous scien-
tific advances that offer hope for clinical benefit.
On the political front, a major focus was inevitably on the U.S.
presidential elections. We applauded President Obama’s deci-
sion to expand federal funding for human embryonic stem cell
research by rescinding the Bush policy of August 9, 2001, which
restricted federally-funded researchers to using only a small
number of cell lines created before that date. The ISSCR
provided comment on draft guidelines for U.S. federal funding
of human embryonic stem cell research, released by the National
Institutes of Health (NIH) in April, and continues to liaise with the
NIH as they implement their final guidelines.
There have also been challenges for the ISSCR this year,
particularly the downturn in the global economy, which has inev-
itably affected the society’s ability to raise money to expand our
activities. It is a worrying time for junior investigators looking for
a job and for scientists at all levels who need to fund their
research programs. Across the world, building projects for new
research institutes have been mothballed.
Of course, we must not be pessimistic, but should take the
longer view. In my opinion, the science budget of any country
should not be the subject of party politics, but an acknowledged
proportion of any government’s expenditure, in the same way as
health care and education. President Obama’s commitment to
devote more than 3% of the U.S. gross domestic product (GDP)
to research and development is an encouraging sign, as is the
European Union’s commitment to invest at least 3% of GDP in
research by 2010. In the UK, there will be an election within the
next 12 months; we British need to remember that since 1997,
there has been a relatively high level of government investment
in research and point out to politicians of all parties the real bene-
fits to the nation that have accrued. I really believe that stem cell
research has the potential to revolutionize our ability to under-
stand, prevent, and treat many different diseases. We must
continue to be evangelical about stem cell research while
carrying out science of the highest possible standard. This brings
me to another success story linked to the ISSCR, namely, our
official affiliated journal, Cell Stem Cell: with its startlingly high
inaugural impact factor of 16.8, the journal is tangible evidence
of the impact and quality of research in our field.As I write this we have just emerged from a tremendously
successful annual meeting in Barcelona. I wish to acknowledge
the tireless work of the annual meeting program committee,
headed by Ronald McKay. Dr. McKay and his team put together
the program in good time, efficiently, and with good humor.
Please also spare a thought for the abstract review teams
who together had to deal with an avalanche of more than 1900
abstracts.
Our hosts in Barcelona were fantastic. Thomas Graf and Juan
Carlos Izpisu´a Belmonte were responsible for bringing the
meeting to Barcelona and deserve our deepest thanks. The
meetingwas cosponsored by theCentre for Genomic Regulation
(CRG) and the Center of Regenerative Medicine in Barcelona
(CMRB). Both of these research institutes have been created
through the initiative of the Government of Catalonia and are
supported by the Spanish Ministry of Education and Science.
In the short space of time that the CRG and CMRB have been
in existence, they have earned an international reputation, illus-
trating the importance of far-sighted regional government in
investing in research.
Membership of the ISSCR has continued to grow this year,
and Barcelona was our largest meeting ever, with the highest
number of early registrations and poster presentations. When
people ask what ISSCR annual meetings are like, the word that
springs to mind is ‘‘circus.’’ By that, I mean the dazzling and
diverse cutting-edge science; new and established investiga-
tors; the academic, clinical and industry input; and the sheer
energy and excitement of it all.
There is, of course, much more to our society than the annual
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ISSCR: Annual Reportstaff, led by the inestimable NancyWitty and Heather Rooke, our
science editor, for making all our activities possible. The execu-
tive committee has given wise advice and worked hard. New
committees this year include the Awards Committee, chaired
by Rusty Gage, and the Clinical Translation Committee, chaired
by David Scadden and Alok Srivastava. I would particularly like
to thank Sean Morrison, who has been a formidable treasurer,
and Peggy Goodell, outgoing chair of the Audit Committee.
In closing, I extend a warm welcome to Irving Weissman, who
is succeeding me as ISSCR president. I know that he will take
a particular interest in alerting the public to unproven stem cell
therapies. Dr. Weissman’s wisdom; stature in the stem cell field;
and experience in the political, academic and private sectors
will all be of great benefit to our society. I well remember the
Keystone symposium that Dr. Weissman organized back in
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hard to describe. The people who gathered at that meeting
were from a range of backgrounds, including immunology
(Weissman) and cell biology (me). Now there are many young
scientists who have only ever been stem cell researchers. A
vibrant research field and a forward-looking, inclusive society
have taken center stage in a few short years.
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